Detailansicht

Wissensnetz

Person

Anca-Ligia Grosu

Radiologin

Name	Anca-Ligia Grosu
Ort	Freiburg im Breisgau (Wirkungsort) Rumänien Deutschland
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Radiologin (charakteristischer Beruf)
Variante	Anca-L. Grosu Anca Ligia Grosu Anca L. Grosu A.-L. Grosu
Beziehung	Universitätsklinikum Freiburg. Klinik für Strahlenheilkunde (2007-)
Weitere Angaben	Dissertation 2000; Dt. Medizinerin, Fachgebiet Strahlentherapie Habilitation 2003; Dt. Medizinerin, Fachgebiet Strahlentherapie
Datensatztyp	Person
GND-Nummer	122079051
Datensatz-ID	122079051
Beteiligt an alle anzeigen ESTRO-EANO guideline on target delineation and radiotherapy for IDHmutant WHO CNS grade 2 and 3 diffuse glioma The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells Correction: Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation Cerebral Metastases in Breast Cancer Patients: a Narrative Review The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction A machine learning approach for predicting biochemical outcome after PSMA-PET–guided salvage radiotherapy in recurrent prostate cancer after radical prostatectomy: retrospective study A multicenter evaluation of different chemotherapy regimens in older adults with head and neck squamous cell carcinoma undergoing definitive chemoradiation A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentation Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models Author correction: Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice Cerebral metastases in breast cancer patients: a narrative review Comparison of data fusion strategies for automated prostate lesion detection using mpMRI correlated with whole mount histology Correction: Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06) Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06) Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells Evaluating the impact of a rigid and a deformable registration method of pre-treatment images for hypoxia-based dose painting Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms = Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer Gross tumor volume imaging: comparison of MRI, FET-PET and perfusion MRI in patients with recurrent glioblastoma Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models Implementation of PET/CT in radiation oncology - a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: a systematic review and meta-analysis Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction Neuroprotection in radiotherapy of brain metastases: A pattern-of-care analysis in Germany, Austria and Switzerland by the German Society for radiation Oncology − working group Neuro-Radio-Oncology (DEGRO AG-NRO) Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07) Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis Proteomic analysis of spatial heterogeneity identifies HMGB2 as putative biomarker of tumor progression in adult-type diffuse astrocytomas Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studies The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT The value of a multimodal approach combining radical surgery and intraoperative radiotherapy in the recurrence treatment of gynecological malignancies - analysis of a large patient cohort in a tertiary care center The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts Toxizität, Progressionsmuster und Überlebensdaten nach Strahlentherapie bei WHO Grad 3 Gliomen Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING = Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/[alpha]PD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING App-controlled treatment monitoring and support for patients with head and neck cancer undergoing radiotherapy: results from a prospective randomized controlled trial Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: multi-center analysis on the value of standard treatment in the elderly Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses Deep Learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy for recurrent prostate cancer Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy DNA-methylome–based tumor hypoxia classifier identifies HPV-negative head and neck cancer patients at risk for locoregional recurrence after primary radiochemotherapy Evaluation of concomitant systemic treatment in older adults with head and neck squamous cell carcinoma undergoing definitive radiotherapy

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Anca-Ligia Grosu

ESTRO-EANO guideline on target delineation and radiotherapy for IDHmutant WHO CNS grade 2 and 3 diffuse glioma

The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET

Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells

Correction: Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation

Cerebral Metastases in Breast Cancer Patients: a Narrative Review

The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy

Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation

Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction

A machine learning approach for predicting biochemical outcome after PSMA-PET–guided salvage radiotherapy in recurrent prostate cancer after radical prostatectomy: retrospective study

A multicenter evaluation of different chemotherapy regimens in older adults with head and neck squamous cell carcinoma undergoing definitive chemoradiation

A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentation

Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models

Author correction: Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice

Cerebral metastases in breast cancer patients: a narrative review

Comparison of data fusion strategies for automated prostate lesion detection using mpMRI correlated with whole mount histology

Correction: Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation

Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation

Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)

Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)

Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells

Evaluating the impact of a rigid and a deformable registration method of pre-treatment images for hypoxia-based dose painting

Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside

Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms = Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer

Gross tumor volume imaging: comparison of MRI, FET-PET and perfusion MRI in patients with recurrent glioblastoma

Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models

Implementation of PET/CT in radiation oncology - a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology

Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: a systematic review and meta-analysis

Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction

Neuroprotection in radiotherapy of brain metastases: A pattern-of-care analysis in Germany, Austria and Switzerland by the German Society for radiation Oncology − working group Neuro-Radio-Oncology (DEGRO AG-NRO)

Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07)

Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis

Proteomic analysis of spatial heterogeneity identifies HMGB2 as putative biomarker of tumor progression in adult-type diffuse astrocytomas

Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas

Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy

The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET

The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy

The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studies

The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy

The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT

The value of a multimodal approach combining radical surgery and intraoperative radiotherapy in the recurrence treatment of gynecological malignancies - analysis of a large patient cohort in a tertiary care center

The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts

Toxizität, Progressionsmuster und Überlebensdaten nach Strahlentherapie bei WHO Grad 3 Gliomen

Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis

The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy

Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities

Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation

App-controlled treatment monitoring and support for patients with head and neck cancer undergoing radiotherapy: results from a prospective randomized controlled trial

Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: multi-center analysis on the value of standard treatment in the elderly

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer

Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses

Deep Learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer

Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy for recurrent prostate cancer

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy

DNA-methylome–based tumor hypoxia classifier identifies HPV-negative head and neck cancer patients at risk for locoregional recurrence after primary radiochemotherapy

Evaluation of concomitant systemic treatment in older adults with head and neck squamous cell carcinoma undergoing definitive radiotherapy